Z-2065-2020 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-2065-2020 was initiated by Becton Dickinson & Company on Apr 16, 2020 and is designated Class II. Reason for recall: This product has been confirmed to exhibit holes in the packaging, which impacts package integrity and potentially compromises a sterile field. The recall status is terminated (terminated Sep 1, 2021). Affected quantity: 16,099,310 units.

Recall details

Product Type
Devices
Report Date
May 27, 2020
Initiation Date
Apr 16, 2020
Termination Date
Sep 1, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16,099,310 units

Product description

BD Posiflush SF Saline Flush Syringe (US Distributed Catalog 306553), UDI 50382903065535

Reason for recall

This product has been confirmed to exhibit holes in the packaging, which impacts package integrity and potentially compromises a sterile field.

Distribution pattern

Nationwide domestic distribution. Foreign distribution to Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK, Australia, Canada, Mexico, Malaysia, New Zealand

Code information

Lots 8353952 9011582 9017875 9024676 9045702 9060999 9079716 9127571 9143529 9156595 9163601

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2065-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2065-2020. Report a data issue: hello@regdatalab.com.